New policing role for pharmacists undermines partnership with prescribers

Pain Medicine (United States)

Volumn 14, Issue 11, 2013, Pages 1619-1620

  Webster, Lynn R ^a,b  

^a American Academy of Pain Medicine   (United States)

^b CRILifetree Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED SUBSTANCE; OPIATE DERIVATIVE;

ARTICLE; ATTRIBUTABLE RISK; CONSULTATION; DRUG EFFICACY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; ELECTRONIC PRESCRIBING; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; ICD-9; LONG TERM CARE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL PRACTICE; PAIN; PATIENT CARE; PATIENT SAFETY; PHARMACIST; PHARMACY; PHYSICIAN; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; PUBLIC HEALTH; STRESS; TREATMENT DURATION;

ANALGESICS, OPIOID; HUMANS; PAIN MANAGEMENT; PHARMACIES; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE;

EID: 84887823128     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12290     Document Type: Editorial

References (7)

1. Walgreens. Good Faith Dispensing Policy. 2012. Available at: http://media.drugwonks.com/media/attachments/51a4a6bb2017a87101000008.pdf?1369745083 (accessed August 2013).
2. Buckley B, Buckley J. Pharmacists feeling pain over restrictive AMA resolution. Pain Medicine News: Policy & Management. Issue: August 2013; Vol. 11.
3. Foreman J. Backlash Against Walgreen's New Painkiller Crackdown. WBUR's Common Health. Aug. 12, 2013.
4. Betses M, Brennan T. Abusive Prescribing of controlled substances-a pharmacy view. N Engl J Med 2013;369:989-991.
5. Houck LK. AMA Tells Pharmacists: "Don't Call Us We'll Call You." FDA Law Blog. June 13, 2013. Available at: http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2013/06/ama-tells-pharmacists-dont-call-us-well-call-you-html. (accessed October 2013).
6. Code of Federal Regulations, Title 21 CFR § 1306 .04 Purpose of issue of prescription.
7. Meier B. Walgreen to Pay $80 Million Fine in D.E.A. Inquiry. New York Times. June 11, 2013.